Medigene AG to present at the Baader Investment Conference 2023
11 sept. 2023 12h30 HE
|
Medigene AG
Planegg/Martinsried, September 11, 2023. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell...
Processa Pharmaceuticals Announces the Appointment of Dr. Khalid Islam to Its Board of Directors
05 nov. 2020 09h15 HE
|
Processa Pharmaceuticals, Inc.
HANOVER, MD, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (“Processa” or the “Company”), a clinical-stage biopharmaceutical company developing products to improve...
Moore Kuehn Encourages IMMU, MOBL, MR, and SCBH Investors to Contact Law Firm
01 oct. 2020 11h35 HE
|
Moore Kuehn
NEW YORK, Oct. 01, 2020 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether...
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of IMMU, VRTU, RST, and CBMG Buyouts
22 sept. 2020 15h00 HE
|
Rigrodsky & Long, P.A.
WILMINGTON, Del., Sept. 22, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: Immunomedics, Inc. (NASDAQ GS: IMMU) regarding possible breaches of fiduciary...
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Immunomedics, Inc. Buyout
14 sept. 2020 13h59 HE
|
Rigrodsky & Long, P.A.
WILMINGTON, Del., Sept. 14, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating Immunomedics, Inc. (“Immunomedics”) (NASDAQ GS: IMMU) regarding possible breaches...
DEADLINE MONDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Immunomedics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
22 févr. 2019 12h35 HE
|
Schall Law
LOS ANGELES, Feb. 22, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Immunomedics, Inc....
Block & Leviton LLP Reminds Shareholders of Important Deadlines; IMMU, PRGO, YRC, NHTC
19 févr. 2019 14h17 HE
|
Block & Leviton LLP
BOSTON, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, reminds investors of the important deadlines...
XPO, AGN, IMMU: Block & Leviton LLP Reminds Shareholders of Important Deadlines
06 févr. 2019 09h56 HE
|
Block & Leviton LLP
BOSTON, Feb. 06, 2019 (GLOBE NEWSWIRE) -- Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, reminds investors of the important deadlines...
INVESTOR DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Immunomedics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
04 févr. 2019 12h50 HE
|
Schall Law
LOS ANGELES, Feb. 04, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Immunomedics, Inc....
INVESTOR NOTICE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Immunomedics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
29 janv. 2019 10h20 HE
|
Schall Law
LOS ANGELES, Jan. 29, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Immunomedics, Inc....